| US Strategy Weekly (5 January 2026) - Stepping into 2026: Continuity and Divergence | Ning Bo | 2026-01-05 |
| 美股市场周报(2026/1/5) - 迈向2026年: 延续与分化 | | 2026-01-05 |
| 港股市场周报 (2026/01/05) - 2026年转型与变革中的港股：开年配置又逢正当时 | 宁铂 | 2026-01-05 |
| HK Strategy Weekly (5 January 2026) - HK Equities in 2026 Transition: A Prime Entry Point for the New Year | Ning Bo | 2026-01-05 |
| China Macro Economy - External disruption may amplify after Chinese New Year | CMS (HK) Research | 2025-12-30 |
| China Macro Economy - Under the Microscope: How to reverse the growth deceleration trend | CMS (HK) Research | 2025-12-29 |
| China Machinery Sector - Data Center Construction Accelerates, Bottlenecks Define Investment Opportunities | CMS (HK) Research | 2025-12-23 |
| 巨子生物（2367 HK）- 增长暂缓，调整开启；评级下调至中性 | 黄铭谦 | 2025-12-22 |
| Giant Biogene (2367 HK) - Growth pauses, reset begins; D/G to HOLD | Wong Ming Him, Joseph | 2025-12-22 |
| Global Pharmaceutical & Healthcare - 2026 Catalysts in Innovative Drugs | Chen Zhuhong, Jonah,Tan Zhen,Chen Hongdao, George | 2025-12-22 |
| 全球医药、医疗行业 - 2026年创新药领域催化剂梳理 | 陈铸鸿,谭震,陈泓道 | 2025-12-22 |
| 美股市场周报(2025/12/22) - 美国经济数据和联储换帅迷雾，关注超跌反弹机会 | 宁铂 | 2025-12-22 |
| US Strategy Weekly (22 December 2025) - U.S. Market Clouded by Economic Data and Fed Leadership Haze; Eyes on Oversold Rebound | Ning Bo | 2025-12-22 |
| HK Strategy Weekly (22 December 2025) - Implications of RMB Appreciation for HK Equities | Ning Bo | 2025-12-22 |
| 港股市场周报 (2025/12/22) - 人民币升值对港股影响几何？ | 宁铂 | 2025-12-22 |
| Auto & Robotics - China–US parallel advances in AD position the sector for an early cyclical breakout | Liang Yonghuo,Harrison, Yin Haocheng | 2025-12-19 |
| 汽车及机器人 - 中美同步推进高阶智驾，智驾板块将率先突破脱离低谷 | 梁勇活,殷浩程 | 2025-12-19 |
| China Macro Economy - Under the Microscope: Service consumption emerging as key driver of household spending growth | CMS (HK) Research | 2025-12-19 |
| Global Pharmaceutical & Healthcare - 2026 Healthcare Outlook: AI-Driven Efficiency Gains, Capex Recovery, and the Clearing of Medtech Policy Headwinds | Chen Zhuhong, Jonah,Tan Zhen,Chen Hongdao, George | 2025-12-18 |
| 全球医药、医疗行业 - 2026年医疗科技行业展望：AI提效、资本开支复苏与医疗器械政策趋稳 | 陈铸鸿,谭震,陈泓道 | 2025-12-18 |